Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
Major Shareholder Will NOT Vote for Merger; Says 'Shareholders Have Already Spoken' by Rejecting Tender Offer at $5.60 per Share
NEW YORK, Sept. 6 /PRNewswire-FirstCall/ -- Elliott Associates, L.P.
(together with funds under common management), a major shareholder of
Mental Health Package Regrettably Undervalues the Role of the GP
AMA President, Dr Mukesh Haikerwal, said today the Government must make changes to its mental health package// if it is to be truly effective in meeting the needs of people with mental illness.
Details of the package were announced today by the Prime Minister, and the AMA welcomes the Governme...
July/August 2009 Annals of Family Medicine tip sheet
...nce-based care of specific diseases) may not necessarily improve the whole (the health of people and populations). He contends that our current system undervalues
care at the level of the whole-person and community, resulting in adverse consequences for the cost, effectiveness and equity of health care. He calls...
CtW Investment Group Believes Longs RE Undervalued - Calls for Greater Disclosure
...n on Longs' part,
since we believe there are reasonable grounds to suspect that the current
tender offer from CVS, which the Longs board has endorsed, undervalues
company's real estate assets. We urge you, as Chairperson of the Longs
board's Governance and Nominating Committee, to immediately disclose any
Sun Pharma Comments on Taro's Potential Sale of Its Irish Operations
...ement less than the real estate value of the facilities? In our view, the agreement in principle with this particular buyer significantly undervalues
the entire facility -- even if one were to take into account only the existing asset base and ignore any future growth potential. If one were...
CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer
...ration of Astellas Pharma Inc.'s $16.00 per share cash offer with its independent financial and legal advisors, it has determined that Astellas' offer undervalues
the Company and is not in the best interests of its stockholders. Accordingly, the Board of Directors recommends that stockholders not tender any of ...
CV Therapeutics' Board of Directors Rejects Astellas Unsolicited Proposal
...he CV Therapeutics board concluded that the Astellas proposal significantly undervalues
the company and is not in the best interests of CV Therapeutics and its sto...f our stockholders. We concluded that
your proposal significantly undervalues
CV Therapeutics and its
potential growth opportunities and we dec...
Despite gains, women still face bias in science careers
...with the ability of women to succeed on the academic science career track and more to do with the cumulative effects of bias and a campus climate that undervalues
women's contributions and potential.
"There is still a lot of covert and overt hostility toward women" on American campuses, Handelsman says. "Some...